线粒体融合蛋白Mfn2抗体,Anti-Mitofusin 2相关产品：
Anti-NHE1抗体说明书，钠氢通道蛋白抗体
Anti-NIK/MAPKKK14抗体说明书，NFkB诱导激酶抗体
Anti-NIS抗体说明书，钠碘转运体蛋白抗体
Anti-NIT2 抗体说明书，抗NIT2蛋白抗体
Anti-NK-1/Substance P Receptor抗体说明书，P物质受体抗体
Anti-NK-2R抗体说明书，神经激肽A受体/K物质受体抗体
Anti-NKA抗体说明书，神经激肽A抗体
Anti-NKB 抗体说明书，神经激肽B抗体
Anti-NKG2A/CD159a/KLRC1抗体说明书，自然杀伤细胞活化性受体2A抗体
Anti-NKG2C抗体说明书， NK细胞受体2C/自然杀伤细胞活化性受体2C抗体
Anti-NKG2D/CD314/KLRK1抗体说明书，NK细胞受体/自然杀伤细胞活化性受体抗体
Anti-NKR抗体说明书，神经激肽B受体抗体
Anti-NKR/Neurokin B receptor抗体说明书，神经激肽-B受体抗体
Anti-Nm23抗体说明书，肿瘤转移抑制基因抗体
Anti-Nm23-H1抗体说明书，肿瘤抑制基因抗体
线粒体融合蛋白Mfn2抗体,Anti-Mitofusin 2Background: B-ATF is a nuclear basic leucine zipper protein that belongs to the
AP-1/ATF superfamily of transcription factors. The leucine zipper of B-ATF mediates
dimerization with members of the Jun family of proteins. The B-ATF protein does not
homodimerize efficiently, but rather forms a heterodimer preferentially with c-Jun. The
B-ATF/c-Jun protein complex can interact with DNA containing a consensus binding
site for AP-1, suggesting that B-ATF functions as a tissue-specific modulator of the
AP-1 transcription complex in human cells. B-ATF also associates with IFP35, a
leucine zipper protein that translocates to the nucleus following IFN treatment. The
gene encoding B-ATF, also designated SFA-2, is strongly expressed in mature T and
B lymphocytes, and is up-regulated after transformation by human T-cell leukemia
virus type I
线粒体融合蛋白Mfn2抗体,Anti-Mitofusin 2Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications
